Vanguard Medical Technologies Inc


Vanguard Medical Technologies Inc (AKA:VMT Inc)
Profile last edited on: 12/5/2016

Developing and commercializing healthcare information technology and medical devices
Year Founded
First SBIR Year
Latest SBIR Award
Program Status


Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

325 Sharon Park Drive Suite 730
Menlo Park, CA 94025
   (650) 777-7970
Multiple Locations:   
Congressional District:   18
County:   San Mate

Public Profile

Vanguard Medical Technologies is an early stage medical technology firm specializing in incubation of promising commercializable technologies that have the potential to disrupt and significantly improve healthcare. Companies incubated within VMT include Wadsworth Medical Technologies (acquired by DQ Holdings) and Health Fidelity (controlling interest acquired by University of Pittsburgh Medical Center). These companies have commercialized products in health IT and medical device. Products are deployed at the leading healthcare institutions and have influenced tens of thousands of lives. The company has a track record of creation of technology from idea to product, with successful spinouts in digital health and medical device. The firm identifies applications and markets that will ultimately support a viable and meaningful product. Then, by supporting physicians and engineers in controlling the earliest stages of technology research within these markets, the firm focuses on producing the most ethical, innovative, and targeted technologies.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
: N/A
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Phase I amount Phase II amount Total Dollars Phase I title Nid
2015 1 NIH 224,712 0 $224,712 Subgroup Analytics and Advanced Semantic Technologies to Enable Personalized Medicine 19194
2011 1 NSF 150,000 0 $150,000 Contextual ASR to Support EHR Adoption 19194
2010 1 NIH 241,875 0 $241,875 Voice Based, Workflow Enhancing, Primary Care Medical Data Input System 19194


  Daniel J Riskin -- Chief Executive Officer

  Kevin Seitter -- Intern

SBIR firms in the news